Axio BioPharma
PrivateLast Round
Seed
Sep 2, 2025
Company Overview
Axio BioPharma is a biotechnology company that operates as a Contract Development and Manufacturing Organization (CDMO) transforming biopharmaceutical manufacturing by using AI to accelerate the development of mammalian-expressed recombinant proteins, with a focus on monoclonal antibodies (mAbs).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical AI, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Axio BioPharma Comps
Public and private peers based on sector, stage, and business model.
Axio BioPharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 2, 2025 |
Key People
Founding team and executive leadership
Axio BioPharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Chemical Angel Network | Seed |
| Chisos Capital | Seed |
Axio BioPharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Axio BioPharma's valuation, stock price, and market status.
